We are monitoring the impact of COVID-19 on Europe Atipamezole Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6476
Share on
Share on

Europe Atipamezole Market Research Report - Segmented By Application, By Route Of Administration & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2019-2024

Pulished: February, 2020
ID: 6476
Pages: 145

Europe Atipamezole Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Atipamezole Market is valued at USD xx billion in 2019 and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2024 during the forecast period 2019-2024. 

Atipamezole is a α2 adrenergic receptor antagonist which is synthetic, suggested for the reversal of analgesic and sedative effects of medetomidine and dexmedetomidine in dogs. It has been researched in humans as well as a potential drug for Parkinson’s disease.

Atipamezole reverses the effects of analgesic and sedative drugs like xylazine, medetomidine, detomidine and amitraz among others in animals. Also in addition, it is used in treating imidazoline and amitraz decongestants toxicity among animals.

Decrease in sedative time of animals decreases the stay in-clinic, decreases hospitalization costs, reduces animal owner revisits, and optimises the time of staff. Also, increasing healthcare expenditure on animals and growing pet ownership are expected to propel the market growth. However, the market is constrained due to factors such as and stringent government regulations associated with the efficacy and safety of atipamezole and adverse effects of atipamezole among others.

This research report segmented and sub-segmented into the following categories:

  • By Application: Anti-Sedatives and Others
  • By Route Of Administration: Intramuscular, Intravenous, Subcutaneous and Intraperitoneal
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Europe has the second largest market in the world for atipamezole by share. In the Europe region, Germany is expected to have the largest market share. Factors such as decreasing hospitalisation costs and time optimisation of staff are expected to propel the market growth in the region.

Key players operating in the Europe Atipamezole Market profiled in this report are Pfizer Inc., Orion Corporation, Alvetra & Werfft GmbH, CP Pharmaceuticals Ltd., Sogeval Laboratories, Inc., VetPharm, Inc., Ceva Sant Animale S.A., Dr. E. Graeub AG, A x ience SAS and Eli Lilly and Company among others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Anti-Sedatives       

                                5.1.2 Others      

                                5.1.3  Y-o-Y Growth Analysis, By Application        

                                5.1.4  Market Attractiveness Analysis, By Application      

                                5.1.5  Market Share Analysis, By Application       

                5.2 Route of Administration                       

                                5.2.1 Intramuscular        

                                5.2.2 Intravenous            

                                5.2.3 Subcutaneous       

                                5.2.4 Intraperitoneal      

                                5.2.5 Y-o-Y Growth Analysis, By Route of Administration               

                                5.2.6 Market Attractiveness Analysis, By Route of Administration             

                                5.2.7 Market Share Analysis, By Route of Administration              

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Application

                                                6.1.3.2 By Route of Administration

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.3.1 By Application

                                                6.1.3.2 By Route of Administration

                                6.1.5  Market Share Analysis      

                                                6.1.3.1 By Application

                                                6.1.3.2 By Route of Administration

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Pfizer Inc.                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Orion Corporation                   

                8.3 Alvetra & Werfft GmbH                        

                8.4 CP Pharmaceuticals Ltd.                        

                8.5 Sogeval Laboratories, Inc.                    

                8.6 VetPharm, Inc.                          

                8.7 Ceva Sant Animale S.A.                         

                8.8 Dr. E. Graeub AG                      

                8.9 A x ience SAS                             

                8.10 Eli Lilly and Company                            

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Atipamezole  Market By Application, From 2019-2024 ( USD Million )
  2. Europe Anti-Sedatives  Market By Region, From 2019-2024 ( USD Million )
  3. Europe Others Market By Region, From 2019-2024 ( USD Million )
  4. Europe Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Million )
  5. Europe Intramuscular Market By Region, From 2019-2024 ( USD Million )
  6. Europe Intravenous Market By Region, From 2019-2024 ( USD Million )
  7. Europe Subcutaneous  Market By Region, From 2019-2024 ( USD Million )
  8. Europe Intraperitoneal Market By Region, From 2019-2024 ( USD Million )
  9. U.K. Atipamezole  Market By Application, From 2019-2024 ( USD Million )
  10. U.K. Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Million )
  11. Germany Atipamezole  Market By Application, From 2019-2024 ( USD Million )
  12. Germany Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Million )
  13. France Atipamezole  Market By Application, From 2019-2024 ( USD Million )
  14. France Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Million )
  15. Italy Atipamezole  Market By Application, From 2019-2024 ( USD Million )
  16. Italy Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Million )
  17. Spain Atipamezole  Market By Application, From 2019-2024 ( USD Million )
  18. Spain Atipamezole  Market By Route of Administration , From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample